OLIGOPROGRESSION

Clinical trials for OLIGOPROGRESSION explained in plain language.

Never miss a new study

Get alerted when new OLIGOPROGRESSION trials appear

Sign up with your email to follow new studies for OLIGOPROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

Can lung cancer patients skip a drug break for radiation?

Disease control Ongoing

This study aims to find out if it's safe and effective for people with a specific type of advanced lung cancer (EGFR-positive NSCLC) to continue taking their daily oral medication, osimertinib, while also receiving radiation therapy. It involves 42 participants who need radiation…

Matched conditions: OLIGOPROGRESSION

Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

OLIGOPROGRESSION

Get alerted when new OLIGOPROGRESSION trials appear

Can lung cancer patients skip a drug break for radiation?